LEGN Overview
Upcoming Projects (LEGN)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (LEGN)
-
A Third View: Perusing the data from the CARTITUDE-4 clinical trial of Carvykti for multiple myeloma which was presented at the 2024 International Myeloma Society Annual Meeting.
Tickers: LEGN, JNJ
Executed On: Nov 19, 2024 at 11:00 AM EST -
A Second View: Perusing the data from the CARTITUDE-4 clinical trial of Carvykti for multiple myeloma which was presented at the 2024 International Myeloma Society Annual Meeting.
Tickers: LEGN, JNJ
Executed On: Nov 05, 2024 at 05:00 PM EST -
Perusing the data from the CARTITUDE-4 clinical trial of Carvykti for multiple myeloma which was presented at the 2024 International Myeloma Society Annual Meeting.
Tickers: LEGN, JNJ
Executed On: Nov 01, 2024 at 01:15 PM EDT -
A second look at the use of Carvykti(ciltacabtagene autoleucel) and Xpovio(selinexor) in multiple myeloma
Tickers: LEGN, KPTI
Executed On: Aug 24, 2022 at 03:00 PM EDT -
A look at the use of Carvykti(ciltacabtagene autoleucel) and Xpovio(selinexor) in multiple myeloma
Tickers: LEGN, KPTI
Executed On: Aug 04, 2022 at 12:00 PM EDT -
A look at the potential of new CAR-T cell therapies in development for multiple myeloma
Tickers: ACLX, GRCL, OriCell Therapeutics, JNJ, LEGN, TSVT
Executed On: Jul 14, 2022 at 08:00 AM EDT -
Discussion on BCMA targeted therapies in multiple myeloma - second look
Tickers: LEGN, TSVT, BMY, JNJ
Executed On: Feb 23, 2022 at 07:00 PM EST -
A look at upcoming Cilta-cel PDUFA and other BCMA directed therapies
Tickers: LEGN, BMY, TSVT, JNJ
Executed On: Feb 17, 2022 at 03:00 PM EST
Upcoming & Overdue Catalysts (LEGN)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (LEGN)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
